Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial

INTRODUCTION: Due to the high prevalence of actinic keratosis (AK) and potential for lesions to become cancerous, clinical guidelines recommend that all are treated. The objective of this study was to evaluate the efficacy and safety of 5-fluorouracil (5-FU) 0.5%/salicylic acid 10% as field-directed...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockfleth, Eggert, von Kiedrowski, Ralph, Dominicus, Rolf, Ryan, John, Ellery, Adam, Falqués, Meritxell, Ivanoff, Nathalie, Azeredo, Rosario Rodriguez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336430/
https://www.ncbi.nlm.nih.gov/pubmed/27995485
http://dx.doi.org/10.1007/s13555-016-0161-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336430/
https://www.ncbi.nlm.nih.gov/pubmed/27995485
http://dx.doi.org/10.1007/s13555-016-0161-2

Ejemplares similares